These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 1080976

  • 21. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J, Zietkiewicz E, Słomski R.
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract] [Full Text] [Related]

  • 22. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis.
    Karsh J, Halbert SP, Anken M, Klima E, Steinberg AD.
    Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853
    [Abstract] [Full Text] [Related]

  • 23. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z.
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T.
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [Abstract] [Full Text] [Related]

  • 25. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S, Błaszczyk M, Górkiewicz A, Jarzabek-Chorzelska M, Rzesa G, Chorzelski T.
    Arch Immunol Ther Exp (Warsz); 1978 Dec; 26(1-6):765-8. PubMed ID: 312085
    [Abstract] [Full Text] [Related]

  • 26. [Detection and clinical evaluation of antibodies against soluble nuclear antigens].
    Sánchez-Ibarrola A.
    Allergol Immunopathol (Madr); 1983 Dec; 11(3):201-6. PubMed ID: 6605081
    [Abstract] [Full Text] [Related]

  • 27. ANAs in systemic rheumatic disease. Diagnostic significance.
    Tan EM, Robinson CA, Nakamura RM.
    Postgrad Med; 1985 Sep 01; 78(3):141-2, 145-8. PubMed ID: 3875842
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD, Turner RA.
    Arthritis Rheum; 1976 Sep 01; 19(5):857-61. PubMed ID: 786297
    [Abstract] [Full Text] [Related]

  • 29. Antinuclear antibodies in diagnosis and management.
    Tan EM.
    Hosp Pract (Off Ed); 1983 Jan 01; 18(1):79-84. PubMed ID: 6401273
    [Abstract] [Full Text] [Related]

  • 30. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
    Cortés JJ, Mendoza F, Reyes PA.
    J Rheumatol; 1987 Aug 01; 14(4):727-31. PubMed ID: 3118019
    [Abstract] [Full Text] [Related]

  • 31. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M, Hodes S, Barland P.
    Am J Med Sci; 1977 Aug 01; 273(1):21-8. PubMed ID: 300568
    [Abstract] [Full Text] [Related]

  • 32. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J.
    Scand J Rheumatol; 1976 Aug 01; 5(3):177-83. PubMed ID: 790556
    [Abstract] [Full Text] [Related]

  • 33. Autoantibodies in the diagnosis of systemic rheumatic diseases.
    von Mühlen CA, Tan EM.
    Semin Arthritis Rheum; 1995 Apr 01; 24(5):323-58. PubMed ID: 7604300
    [Abstract] [Full Text] [Related]

  • 34. Mixed connective tissue disease in childhood. Relationship Sjögren's syndrome.
    Fraga A, Gudiño J, Ramos-Niembro F, Aiarcón-Segovia D.
    Am J Dis Child; 1978 Mar 01; 132(3):263-5. PubMed ID: 629242
    [Abstract] [Full Text] [Related]

  • 35. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
    Mulli JC, Cruchaud A.
    Int Arch Allergy Appl Immunol; 1977 Mar 01; 53(3):279-89. PubMed ID: 300712
    [Abstract] [Full Text] [Related]

  • 36. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M, Fritzler MJ, Blüthner M.
    Arthritis Res Ther; 2005 Mar 01; 7(1):R19-29. PubMed ID: 15642139
    [Abstract] [Full Text] [Related]

  • 37. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM, Bunn C, Hughes GR, Buchanan WW, Dick WC.
    Ann Rheum Dis; 1977 Oct 01; 36(5):442-7. PubMed ID: 921344
    [Abstract] [Full Text] [Related]

  • 38. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.
    Tan EM.
    Adv Immunol; 1989 Oct 01; 44():93-151. PubMed ID: 2646863
    [No Abstract] [Full Text] [Related]

  • 39. Recently characterised autoantibodies and their clinical significance.
    Sturgess A.
    Aust N Z J Med; 1992 Jun 01; 22(3):279-89. PubMed ID: 1497555
    [Abstract] [Full Text] [Related]

  • 40. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G, Hiepe F.
    Z Arztl Fortbild (Jena); 1992 Mar 10; 86(5):217-22. PubMed ID: 1585674
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.